Organon: Certainly A Risky Bet, But Looks Increasingly Compelling (Upgrade)

Group 1 - The article discusses the author's long positions in several pharmaceutical companies, including ABBV, MRK, AMGN, JNJ, and RHHBF, indicating a positive outlook on these stocks [1] - There is a mention of a potential long position in Organon & Co. within the next 72 hours, suggesting an interest in this stock as well [2] Group 2 - The article emphasizes that past performance is not indicative of future results, highlighting the inherent uncertainty in investment outcomes [3] - It clarifies that no specific investment recommendations are provided, and the views expressed may not represent the broader platform's stance [3]